Publication | Open Access

Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

Cell TherapyTransplantationMarrow TransplantationChronic Lymphocytic LeukemiaFirst Patient TreatedStem Cell TransplantationImmunologyHematologyAutoimmunityCell TransplantationBlood TransplantationDramatic RegressionImmunotherapyMedicineRadiation OncologyAdult T-cell Leukemia-lymphomaHealth Sciences